Michele Anderson
Equibles does not estimate personal net worth.
About Michele Anderson
Assembly Biosciences, Inc. reported in an 8-K filed July 20, 2022 that Michele Anderson was appointed Chief Development Officer, effective August 1, 2022. Assembly Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Assembly Biosciences, Inc. includes Jason A. Okazaki (CEO, COO and Board Member), John G. McHutchison, A.O., M.D. (Chairman and Board Member), Jeanette M. Bjorkquist (CFO) and 7 others.
“Michele Anderson, SVP of development operations at Assembly Bio, has been appointed as chief development officer effective August 1, 2022, and will assume responsibility for the company's development organization.”
Affiliation history
-
Current
2022-08-01–present
Company network
Leadership on record at Assembly Biosciences, Inc.
- Jason A. Okazaki CEO, COO, Board Member
- John G. McHutchison, A.O., M.D. Chairman, Board Member
- Jeanette M. Bjorkquist CFO
- Michael P. Samar CFO, Chief Accounting Officer
- Thomas J. Russo CFO
- Alan J. Lewis Board Member
- Anthony E. Altig Board Member
- Gina Consylman Board Member
- Helen S. Kim Board Member
- John G. McHutchison Board Member